Douglas H.J. Elder

1.1k total citations
24 papers, 777 citations indexed

About

Douglas H.J. Elder is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Douglas H.J. Elder has authored 24 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 10 papers in Pulmonary and Respiratory Medicine and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Douglas H.J. Elder's work include Cardiovascular Function and Risk Factors (8 papers), Cardiac Arrhythmias and Treatments (5 papers) and Heart Failure Treatment and Management (5 papers). Douglas H.J. Elder is often cited by papers focused on Cardiovascular Function and Risk Factors (8 papers), Cardiac Arrhythmias and Treatments (5 papers) and Heart Failure Treatment and Management (5 papers). Douglas H.J. Elder collaborates with scholars based in United Kingdom, Australia and United States. Douglas H.J. Elder's co-authors include Chim C. Lang, Brian J. Lipworth, Philip Short, Stuart Schembri, Samuel Lipworth, Anna Maria Choy, Allan D. Struthers, Alex S. F. Doney, George Casella and Stuart D. Pringle and has published in prestigious journals such as Journal of the American College of Cardiology, CHEST Journal and BMJ.

In The Last Decade

Douglas H.J. Elder

24 papers receiving 749 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas H.J. Elder United Kingdom 13 494 353 127 119 109 24 777
Kazunori Omote Japan 16 794 1.6× 149 0.4× 91 0.7× 94 0.8× 120 1.1× 56 966
Klaus Klausen Denmark 6 436 0.9× 105 0.3× 58 0.5× 81 0.7× 195 1.8× 8 786
Nikki Earle New Zealand 13 803 1.6× 164 0.5× 70 0.6× 43 0.4× 96 0.9× 31 961
Iolanda Enea Italy 14 648 1.3× 131 0.4× 34 0.3× 139 1.2× 99 0.9× 33 867
Yumiko Miyake United States 7 332 0.7× 127 0.4× 58 0.5× 61 0.5× 77 0.7× 10 473
Franz Weidinger Austria 5 379 0.8× 122 0.3× 77 0.6× 34 0.3× 60 0.6× 12 539
Nicholas D. Gollop United Kingdom 9 241 0.5× 171 0.5× 34 0.3× 60 0.5× 121 1.1× 24 456
Hidemi Sorimachi Japan 20 1.1k 2.3× 188 0.5× 98 0.8× 94 0.8× 200 1.8× 58 1.3k
Alexander Limburg Netherlands 5 634 1.3× 87 0.2× 57 0.4× 82 0.7× 87 0.8× 9 791
J TSalonen 3 535 1.1× 284 0.8× 35 0.3× 73 0.6× 184 1.7× 4 714

Countries citing papers authored by Douglas H.J. Elder

Since Specialization
Citations

This map shows the geographic impact of Douglas H.J. Elder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas H.J. Elder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas H.J. Elder more than expected).

Fields of papers citing papers by Douglas H.J. Elder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas H.J. Elder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas H.J. Elder. The network helps show where Douglas H.J. Elder may publish in the future.

Co-authorship network of co-authors of Douglas H.J. Elder

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas H.J. Elder. A scholar is included among the top collaborators of Douglas H.J. Elder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas H.J. Elder. Douglas H.J. Elder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grubb, Neil R., et al.. (2019). Atrial fibrillation case finding in over 65 s with cardiovascular risk factors – Results of initial Scottish clinical experience. International Journal of Cardiology. 288. 94–99. 6 indexed citations
2.
Elder, Douglas H.J., Jagdeep Singh, Daniel L. Levin, et al.. (2015). Mean HbA1c and Mortality in Diabetic Individuals with Heart Failure: A Population Cohort Study. European Journal of Heart Failure. 18(1). 94–102. 69 indexed citations
3.
Short, Philip, William J. Anderson, Douglas H.J. Elder, Allan D. Struthers, & Brian J. Lipworth. (2015). Impact of Left Ventricular Hypertrophy on Survival in Chronic Obstructive Pulmonary Disease. Lung. 193(4). 487–495. 9 indexed citations
4.
Elder, Douglas H.J., et al.. (2015). Characterizing Patients with Chronic Heart Failure in Community Care After Hospitalization: A Potential Role for Ivabradine. Cardiovascular Therapeutics. 33(3). 104–108. 6 indexed citations
5.
Elder, Douglas H.J., et al.. (2014). Effect of Warfarin on Survival in Patients with Concomitant Left Ventricular Systolic Dysfunction and Pulmonary Hypertension: A Population Cohort Study. European Journal of Heart Failure. 17(1). 90–97. 9 indexed citations
6.
Pauriah, Maheshwar, Douglas H.J. Elder, Simon Ogston, et al.. (2014). High-potency statin and ezetimibe use and mortality in survivors of an acute myocardial infarction: a population-based study. Heart. 100(11). 867–872. 16 indexed citations
7.
Parry, Helen, Louise A. Donnelly, Natalie Van Zuydam, et al.. (2013). Genetic variants predicting left ventricular hypertrophy in a diabetic population: a Go-DARTS study including meta-analysis. Cardiovascular Diabetology. 12(1). 109–109. 13 indexed citations
8.
Jia, Lin, S. Ogston, Charlotte Hall, et al.. (2013). 009 ADHERENCE TO HEART FAILURE THERAPY AND OUTCOME: A POPULATION BASED STUDY. Heart. 99(suppl 2). A12.1–A12. 1 indexed citations
9.
Elder, Douglas H.J., et al.. (2012). Aortic valvular heart disease: is there a place for angiotensin-converting-enzyme inhibitors?. Expert Review of Cardiovascular Therapy. 11(1). 107–114. 7 indexed citations
10.
Pauriah, Maheshwar, Faisel Khan, Tiong K. Lim, et al.. (2012). B-type natriuretic peptide is an independent predictor of endothelial function in man. Clinical Science. 123(5). 307–312. 22 indexed citations
11.
Szwejkowski, Benjamin R., Douglas H.J. Elder, Anna Maria Choy, et al.. (2011). Pulmonary Hypertension Predicts All-Cause Mortality in Patients with Heart Failure: A Retrospective Cohort Study. European Journal of Heart Failure. 14(2). 162–167. 46 indexed citations
12.
Nadir, M. Adnan, Li Wei, Douglas H.J. Elder, et al.. (2011). Impact of Renin-Angiotensin System Blockade Therapy on Outcome in Aortic Stenosis. Journal of the American College of Cardiology. 58(6). 570–576. 113 indexed citations
13.
Elder, Douglas H.J., Li Wei, Benjamin R. Szwejkowski, et al.. (2011). The Impact of Renin-Angiotensin-Aldosterone System Blockade on Heart Failure Outcomes and Mortality in Patients Identified to Have Aortic Regurgitation. Journal of the American College of Cardiology. 58(20). 2084–2091. 41 indexed citations
14.
Choy, Anna Maria, Douglas H.J. Elder, Awsan Noman, et al.. (2011). Right ventricular pacing impairs endothelial function in man. EP Europace. 13(6). 853–858. 8 indexed citations
15.
Elder, Douglas H.J., Chim C. Lang, & Anna Maria Choy. (2011). Pacing-induced heart disease: understanding the pathophysiology and improving outcomes. Expert Review of Cardiovascular Therapy. 9(7). 877–886. 26 indexed citations
16.
Short, Philip, Samuel Lipworth, Douglas H.J. Elder, Stuart Schembri, & Brian J. Lipworth. (2011). Effect of   blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study. BMJ. 342(may10 2). d2549–d2549. 191 indexed citations
17.
Elder, Douglas H.J., Chim C. Lang, Sushma Rekhraj, et al.. (2011). Renin–angiotensin system blockers are associated with reduced mortality and heart failure hospitalization in patients paced for complete atrioventricular block. Heart Rhythm. 9(4). 505–510. 3 indexed citations
18.
Singanayagam, Aran, Douglas H.J. Elder, & James D. Chalmers. (2011). Is community-acquired pneumonia an independent risk factor for cardiovascular disease?. European Respiratory Journal. 39(1). 187–196. 54 indexed citations
19.
Short, Philip, Peter A. Williamson, Douglas H.J. Elder, et al.. (2011). The Impact of Tiotropium on Mortality and Exacerbations When Added to Inhaled Corticosteroids and Long-Acting β-Agonist Therapy in COPD. CHEST Journal. 141(1). 81–86. 71 indexed citations
20.
Elder, Douglas H.J., Maheshwar Pauriah, Chim C. Lang, et al.. (2010). Is there a Failure to Optimize theRapy in anGina pEcToris (FORGET) study?. QJM. 103(5). 305–310. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazunori Omote Breakdown of academic impact, for papers by Klaus Klausen Breakdown of academic impact, for papers by Nikki Earle Breakdown of academic impact, for papers by Iolanda Enea Breakdown of academic impact, for papers by Yumiko Miyake Breakdown of academic impact, for papers by Franz Weidinger Breakdown of academic impact, for papers by Nicholas D. Gollop Breakdown of academic impact, for papers by Hidemi Sorimachi Breakdown of academic impact, for papers by Alexander Limburg Breakdown of academic impact, for papers by J TSalonen
Rankless by CCL
2026